Navigation Links
Quality standards for biological, chemical drugs and public health are focus of India meeting

Rockville, Md., January 24, 2011 In collaboration with key stakeholders, the United States Pharmacopeial Convention (USP) and the Indian Pharmacopoeia Commission (IPC) will host the 2011 IPC-USP 10th Science & Standards Symposium on February 17 and 18, 2011 in Hyderabad, India. The event reflects India's rise as a supplier of medicines worldwide, bringing USP closer to its Indian counterpart in the interest of promoting global public health.

The symposium aims to facilitate a science-based dialogue among key stakeholderssuch as standard-setting bodies, government officials, policy makers, pharmaceutical manufacturers and academiato address relevant topics affecting the region and thereby promote access to quality medicines. Attendees will have the opportunity to network with thought leaders, obtain industry benchmark information and contribute early in the standard-setting process for both IPC and USP.

Along with USP and IPC, additional co-sponsors include Bulk Drug Manufacturers Association (BDMA), Indian Drug Manufacturers' Association (IDMA), Organization of Pharmaceutical Producers of India (OPPI) and Pharmacy Council of India (PCI).

"For a decade, these annual IPC-USP meetings have brought together key experts and innovators throughout the Indian pharmaceutical landscape as well from the United States and other countries," said Roger L. Williams, M.D., chief executive officer, USP. "As India's role in the global pharmaceutical industry continues its rapid growth, collaborations within India and with partners around the world are essential to helping to ensure public health." Previous events were known as Annual Scientific Meetings.

Sessions on chemical drugs will be part of symposium highlights, covering topics as varied as quality by design, standards-setting, impurities, chemical reference materials/uncertainty measurement and strategies for combating counterfeit drugs. Biological drugs will also be emphasized in sessions that explore regulatory approaches; standards for biologics and biotechnology drugs; critical quality attributes; reference materials; standards for vaccines and monoclonal antibodies and strategies for combating adulteration of drugs.

"The IPC values its longstanding relationship with USP," stated G.N. Singh, Ph.D., secretary-cum-scientific director, IPC. "We are confident this year's forum will result in a better understanding among participants of the status and issues facing the IPC and USP in standards-setting."


Contact: Theresa Laranang-Mutlu
US Pharmacopeia

Related biology news :

1. CU-Boulder study suggests air quality regulations miss key pollutants
2. Biological sand filters, a practical approach to combat poverty and inequality
3. New standard for popular stevia-based sweetener to assure products quality
4. New research shows high-quality protein in eggs contributes to power, strength and energy
5. Healthy food availability could depend on where you live -- so does the quality of your diet
6. Houseplants increase quality of life for retirement community residents
7. Enhanced quality of LIFE through Nordic food
8. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
9. Quality and purity of popular stevia sweetener strengthened by new reference standards
10. Dietary supplements manufacturers gain new tool to help ensure quality products
11. Improved air quality during Beijing Olympics could inform pollution-curbing policies
Post Your Comments:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), ... MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing ... AMA members have embraced this type of racing and several new model aviation pilots ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
Breaking Biology Technology: